2024 Italy Hospital Infectious Disease Market
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
2024 Italy Hospital Infectious Disease Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for 100 Tests, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
This new report from contains 891 pages and 75 tables.
The report is available by section, and can be customized to specific information needs and budget.
The report presents a comprehensive analysis of the Japanese hospital infectious disease testing market, including:
- Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.;
- Current scientific views on definition, epidemiology, and etiology of major infectious diseases and microorganisms.;
- Volume and sales forecasts for 80 infectious disease tests performed in Japanese hospital laboratories.;
- Instrumentation technologies and feature comparison of leading analyzers.;
- Sales and market shares of leading suppliers.;
- Emerging diagnostic technologies and their potential market applications.;
- Product development opportunities.;
- Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.;
- Business opportunities and strategic recommendations for suppliers.
Contains 891 pages and 75 tables
TABLE OF CONTENTSIntroduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Adenovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. Aeromonas
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Anthrax/Bacillus Anthracis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Arboviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Babesiosis
a. Background
7. Bacillary Epithelioid Angiomatosis (BEA) And Other
Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Blastocystis Hominis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. Brucella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. Campylobacter
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
11. Candida
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. Chagas Disease
a. Background
13. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. Chlamydia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
15. Clostridium Difficile
a. Background
b. Diagnostic Tests
c. Drugs and Vaccines
16. Coronaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. Coxsackieviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
18. Creutzfeldt-Jakobs Disease
a. Background
b. Diagnostic Tests
c. Vaccines
19. Cryptosporidium Parvum
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
20. Cyclospora Cayetanensis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
21. Cytomegalovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
22. Ebola Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
23. E. Coli
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
24. EchoVirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
25. Encephalitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
26. Enteroviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
27. Epstein-Barr Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
28. Giardia Lamblia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
29. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
30. Granuloma Inguinale
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
31. Hantavirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
32. Helicobacter Pylori
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
33. Hepatitis
a. Background
b. Hepatitis A
c. Hepatitis B
d. Hepatitis C
e. Vaccines and Drugs
34. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
35. Human Herpes Virus-6 (HHV-6)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
36. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
37. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
38. Lyme Disease
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
39. Lymphogranuloma Venereum (LGV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
40. Malaria
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
41. Measles (Rubeola)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
42. Meningitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
43. Microsporidium
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
44. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
45. Mumps
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
46. Mycoplasma
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
47. Papillomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
48. Parvovirus B19
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
49. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
50. Polyomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
51. Pseudomonas Aeruginosa
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
52. Rabies
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
53. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
54. RhinoViruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
55. RotaVirus (REOVIRUS)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
56. Rubella(MEASLES)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
57. Salmonellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
58. Septicemia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
59. Shigellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
60. Staphylococcus Aureus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
61. Streptococci
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
62. Syphilis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
63. Toxoplasmosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
64. Trichomonas Vaginalis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
65. Tuberculosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
66. Vibrio
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
67. West Nile Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
68. Yersina
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed by Abbott,
Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and
Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Computers, Software and Automation
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
Cepheid
Decode Genetics
Diamedix
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
GSK Biologicals
Hologic
Illumina
LabCorp
Leica Biosystems
Li-Cor Biosciences
Lonza
Myriad Genetics
Ortho-Clinical Diagnostics
PerkinElmer
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
SeraCare
Shimadzu
Siemens Healthineers
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher
WakoList Of Tables
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus
Tests
Major Companies Developing or Marketing Bartonella
Tests
Major Companies Developing or Marketing
Campylobacter Tests
Major Companies Developing or Marketing Candida
Tests
Major Companies Developing or Marketing Chlamydia
Tests
Major Companies Developing or Marketing Clostridium
Tests
Major Companies Developing or Marketing Coronavirus
Tests
Major Companies Developing or Marketing Cryptosporidium
Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus
Tests
Major Companies Developing or Marketing Enterovirus
Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia
Tests
Major Companies Developing or Marketing Gonorrhea
Tests
Major Companies Developing or Marketing Hantavirus
Tests
Major Companies Developing or Marketing Helicobacter
Pylori Tests
Major Companies Developing or Marketing Hepatitis
Tests
Major Companies Developing or Marketing Herpes
Tests
Major Companies Developing or Marketing Influenza
Tests
Major Companies Developing or Marketing Legionella
Tests
Major Companies Developing or Marketing Lyme Disease
Tests
Major Companies Developing or Marketing Lymphogranuloma
Tests
Major Companies Developing or Marketing Malaria
Tests
Major Companies Developing or Marketing Measles
Tests
Major Companies Developing or Marketing Meningitis
Tests
Major Companies Developing or Marketing Microsporidium
Tests
Major Companies Developing or Marketing
Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma
Tests
Major Companies Developing or Marketing Papilloma
Virus Tests
Major Companies Developing or Marketing Parvovirus
Tests
Major Companies Developing or Marketing Pneumonia
Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus
Tests
Major Companies Developing or Marketing Rubella
Tests
Major Companies Developing or Marketing Salmonella
Tests
Major Companies Developing or Marketing Septicemia
Tests
Major Companies Developing or Marketing Shigella
Tests
Major Companies Developing or Marketing Staphylococci
Tests
Major Companies Developing or Marketing
Streptococci Tests
Major Companies Developing or Marketing Syphilis
Tests
Major Companies Developing or Marketing Toxoplasmosis
Tests
Major Companies Developing or Marketing Trichomonas
Tests
Major Companies Developing or Marketing Tuberculosis
Tests
Major Companies Developing or Marketing West Nile
Tests
Major Companies Developing or Marketing Yersinia Tests
Japan Summary Table
All Infectious Diseases Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan
Hospital Laboratories Performing Infectious Disease
Tests by Bed Size
Japan
Hospital Laboratories Infectious Disease Test
Volume Forecast
Japan
Hospital Laboratories Infectious Disease Diagnostics
Market Forecast
Japan
AIDS Testing Market Diagnostics Sales by
Major Supplier
Japan
Campylobacter Testing Market Diagnostics Sales by Major
Supplier
Japan
Candida Testing Market Diagnostics Sales by
Major Supplier
Japan
Chlamydia Testing Market Diagnostics Sales by
Major Supplier
Japan
CMV Testing Market Diagnostics Sales by
Major Supplier
Japan
Gonorrhea Testing Market Diagnostics Sales by
Major Supplier
Japan
Hepatitis Testing Market Diagnostics Sales by Major
Supplier
Japan
Hepatitis C Testing Market Diagnostics Sales by Major
Supplier
Japan
Herpes Testing Market Diagnostics Sales by
Major Supplier
Japan
Legionella Testing Market Diagnostics Sales Forecast by Major
Supplier
Japan
Meningitis Testing Market Diagnostics Sales by Major
Supplier
Japan
Mononucleosis Testing Market Diagnostics Sales by Major
Supplier
Japan
Mycoplasma Testing Market Diagnostics Sales by
Major Supplier
Japan
Pneumonia Testing Market Diagnostics Sales by
Major Supplier
Japan
RSV Testing Market Diagnostics Sales by Major Supplier
Japan
Rotavirus Testing Market Diagnostics Sales by Major
Supplier
Japan
Rubella Testing Market Diagnostics Sales by Major
Supplier
Japan
Septicemia Testing Market Diagnostics Sales by Major
Supplier
Japan
Shigella Testing Market Diagnostics Sales by Major
Supplier
Japan
Streptococci Testing Market Diagnostics Sales by Major
Supplier
Japan
Syphilis Testing Market Diagnostics Sales by Major
Supplier
Japan
Toxoplasmosis Testing Market Diagnostics Sales by Major
Supplier
Japan
Trichomonas Testing Market Diagnostics Sales by
Major Supplier
Japan
Tuberculosis Testing Market Diagnostics Sales by Major
SupplierRELATED REPORTS2024 U.S. Hospital Virology and Bacteriology Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Technologies Instrumentation and Opportunities
2024 U.S. Hospital Virology and Bacteriology Testing Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and OpportunitiesThis new report from contains 997 pages and 87
View Report2024 U.K. Hospital Virology and Bacteriology Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Technologies Instrumentation and Opportunities
2024 U.K. Hospital Virology and Bacteriology Testing Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and OpportunitiesThis new report from contains 886 pages and 67
View Report2024 Italy Hospital Virology and Bacteriology Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Technologies Instrumentation and Opportunities
2024 Italy Hospital Virology and Bacteriology Testing Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and OpportunitiesThis new report from contains 887 pages and 72
View Report2024 Italy Hepatitis Diagnostic Testing Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals Blood Banks Commercial Labs POC Locations
2024 Italy Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations The
View ReportSAMPLE REQUESTFill The Form For Sample Request
REVIEWSThere is no Reviews available
